Journals / The Journal of Pediatric Research / 2019 / Cilt: 6 - Sayı: 2

Can Serial Measurement Enhance the Diagnostic Value of Procalcitonin as a Marker of Gram-negative Bacteremia in Children with Acute Leukemia?

Pages
99–103
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study also demonstrated that PCT could be used to rule out bacterial infections particularly caused byGram-negative bacteria.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Despite improvements in diagnosis and treatment, infections are still major cause of morbidity and mortality in children with febrileneutropenia (FN).
📊
Key Findings & Data:Therefore, it is important to distinguish infections from other non-infectious causes, for both to chooseappropriate antibiotic and to reduce the redundant antibiotic use.Materials and Methods: In this retrospective study, we aim to evaluate serial procalcitonin (PCT) levels for predicting bacteremia particularlycaused by Gram-negative microorganism.Results: Among FN episodes caused by Gram-negative microorganism, the median level of second PCT sample obtained between 48 and72 hours PCT 2 was found to be significantly higher when compared to infections caused by Coagulase-negative Staphylococcus or culturenegative confirmed infections, p value was 0.003; however, fever onset PCT 1 and C-reactive protein (CRP) 1 values showed no significantdifference (p>0.05).
💡
Conclusion & Impact:This study also demonstrated that PCT could be used to rule out bacterial infections particularly caused byGram-negative bacteria.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aim: Despite improvements in diagnosis and treatment, infections are still major cause of morbidity and mortality in children with febrileneutropenia (FN). In these patients, due to inadequate inflammatory response and subtle clinical symptoms, to determine the sourceof infection can be challenging. Therefore, it is important to distinguish infections from other non-infectious causes, for both to chooseappropriate antibiotic and to reduce the redundant antibiotic use.Materials and Methods: In this retrospective study, we aim to evaluate serial procalcitonin (PCT) levels for predicting bacteremia particularlycaused by Gram-negative microorganism.Results: Among FN episodes caused by Gram-negative microorganism, the median level of second PCT sample obtained between 48 and72 hours PCT 2 was found to be significantly higher when compared to infections caused by Coagulase-negative Staphylococcus or culturenegative confirmed infections, p value was 0.003; however, fever onset PCT 1 and C-reactive protein (CRP) 1 values showed no significantdifference (p>0.05). The area under curve values demonstrated by receiver operating characteristic (ROC) analysis for CRP 1, CRP 2, PCT 1, PCT2 were 0.664, 0.748, 0.504 and 0.842, respectively.Conclusion: This study showed that initial PCT levels were not significantly correlate with culture-confirmed bacterial infection. Therefore,initial PCT values do not help the clinicians in terms of administering or postponing empirical antibiotics at the time of fever onset. However,third day PCT levels present as a good diagnostic marker due to a higher sensitivity and specificity when comparing them to the initial values.Determination of serial PCT may enhance the diagnostic value of PCT diagnostic marker in FN episodes caused by Gram-negative bacteriawith a high sensitivity (87.5%). This study also demonstrated that PCT could be used to rule out bacterial infections particularly caused byGram-negative bacteria.

🔖

Cite This Article

BAL, Z. Ş., ERCAN, G., KARAPINAR, D. Y. (2019). Can Serial Measurement Enhance the Diagnostic Value of Procalcitonin as a Marker of Gram-negative Bacteremia in Children with Acute Leukemia?. The Journal of Pediatric Research, Cilt: 6 - Sayı: 2, 99–103. https://ajindex.com/articles/362771

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Barton CD, Waugh LK, Nielsen MJ, Paulus S. Febrile neutropenia in children treated for malignancy. J Infect 2015;71(Suppl 1):27-35
  2. Haeusler GM, Sung L, Ammann RA, Phillips B. Management of fever and neutropenia in paediatric cancer patients: room for improvement? Curr Opin Infect Dis 2015;28:532-8. 3. de Naurois J, Novitzky-Basso I, Gill MJ, et al. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol 2010;2:252-6
  3. Hoeboer SH, van der Geest PJ, Nieboer D, Groeneveld AB. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect 2015;21:474-81
  4. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and metaanalysis. Lancet Infect Dis 2013;13:426-35
  5. Wu CW, Wu JY, Chen CK, et al. Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis. Support Care Cancer 2015;23:2863-72
  6. Bruno B, Busca A, Vallero S, et al. Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients. Expert Rev Hematol 2017;10:543-50
  7. Sbrana A, Torchio M, Comolli G, et al. Use of procalcitonin in clinical oncology: a literature review. New Microbiol 2016;39:174-80
  8. Hemming V, Jakes AD, Shenton G, Phillips B. Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia. BMC Pediatr 2017;17:2
  9. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 2011;52:56-93
  10. Sirinoglu M, Soysal A, Karaaslan A, et al. The diagnostic value of soluble urokinase plasminogen activator receptor compared with C-reactive protein and procalcitonin in children with febrile neutropenia. Pediatr Hematol Oncol 2016;33:200-8
  11. Demirkaya M, Tugcu D, Akcay A, et al. Adrenomedullin-A new marker in febrile neutropenia: comparison with CRP and procalcitonin. Pediatr Hematol Oncol 2015;32:482-9
  12. Hitoglou-Hatzi S, Hatzistilianou M, Gougoustamou D, et al. Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia. Clin Exp Med 2005;5:60-5
  13. Kitanovski L, Jazbec J